Kaiser Permanente Shares HIV Best Practices
Kaiser Permanente, the largest nonprofit health care provider in the U.S., issued a challenge today to private health care providers and public and community health clinics to increase the number of HIV-positive people getting effective treatment by sharing Kaiser Permanente’s toolkit of clinical best practices, provider and patient education materials, mentoring, training and health IT expertise.
The HIV Challenge was announced at the Center for Medicare & Medicaid Innovation Care Innovations Summit in Washington, D.C.
Kaiser Permanente has treated more than 60,000 people with HIV in the last thirty years, and announced that it has reduced disparities among its current HIV population of more than 20,000 people by working to meet or exceed the objectives of the U.S. National HIV AIDS Strategy.
HIV clinical care outcomes announced by Kaiser Permanente include:
- HIV mortality rates that are half the national average
- More than 90 percent median treatment adherence among patients regularly in care and on antiretroviral therapy
- No disparities among its black and Latino HIV-positive patients for both mortality and medication rates, compared to a 15 percent higher rate in the United States for mortality and for medication
- Among Kaiser Permanente's HIV-positive patients, 89 percent are in HIV-specific care within 90 days—compared to 50 percent of HIV-positive patients in the U.S. getting this kind of care within one year
- Nearly 70 percent of all Kaiser Permanente's HIV-positive patients have maximal viral control, compared to 19 to 35 percent nationally
The tools being shared by Kaiser Permanente include:
- Quality improvement programs that measure gaps in care;
- Testing, prevention and treatment guidelines;
- Multi-disciplinary care team models that emphasize the medical home so HIV specialists, care managers, clinical pharmacists and providers work together; and
- Education for both the provider and patient.
Weigh In: Does your community have an HIV best practice that could improve detection and care in the U.S.? What about prevention